Ultrasound device shows promise in breaking up pulmonary embolisms: Research

A tiny ultrasound device that helps dissolve blood clots is showing promise in breaking up potentially deadly pulmonary embolisms (PEs), blockages of blood vessels in the lungs that can occur after long plane rides, surgery and extended bed rest. Research on the largest group of patients treated with this method to date will be presented at the 23rd annual International Symposium on Endovascular Therapy (ISET).

In the study, 27 patients with significant PEs were treated at East Jefferson General Hospital in Metairie, La. All survived and each benefitted from a significant reduction in right heart chamber size. On average, the size of each clot was reduced by more than half. Four patients suffered from major bleeding and two from minor bleeding. There were no bleeding complications in patients who received a lower dose of clot-busting drugs.

"This method may revolutionize the way we treat patients with large PEs," said Tod Engelhardt, M.D., chairman of the Cardiovascular and Thoracic Surgery Division at East Jefferson General Hospital, and assistant professor of surgery at Tulane University School of Medicine in New Orleans. "These are patients who were saved and prevented from going into heart failure."

In traditional therapy, clot-busting drugs are delivered to the blockage, but the method can take many hours or even days. In the ultrasound method, the device is advanced through blood vessels to the site of the blockage, where it emits sound waves that loosen the clot, allowing the clot-busting drugs to dissolve it faster. The method currently is used to treat blood clots in the legs (called deep vein thrombosis or DVT) and other parts of the body.

PE can occur after part of a clot in another part of the body - often the legs - breaks off and travels through the heart, lodging in a lung artery. Risk factors for developing PE include obesity, smoking and high blood pressure. About 60,000 people with DVT die every year, most of them from PE.

Source:

East Jefferson General Hospital

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine